Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125140012 | 12514001 | 2 | F | 201409 | 20160721 | 20160630 | 20160912 | PER | US-JNJFOC-20160527730 | JANSSEN | 30.94 | YR | A | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125140012 | 12514001 | 1 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 22406 | 20 | MG | TABLET | ||||||
125140012 | 12514001 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | U | 0 | 81 | MG | TABLET | |||||||
125140012 | 12514001 | 3 | SS | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | Oral | U | 0 | 75 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125140012 | 12514001 | 1 | Pulmonary embolism |
125140012 | 12514001 | 2 | Product used for unknown indication |
125140012 | 12514001 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125140012 | 12514001 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125140012 | 12514001 | Syncope | |
125140012 | 12514001 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125140012 | 12514001 | 1 | 20140605 | 20140917 | 0 |